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Abstract Mycobacterium tuberculosis represents a
severe threat to human health worldwide. Therefore, it is
important to expand our knowledge of vital mycobacterial
processes, such as that eVected by fatty acid synthase type 2
(FASII), as well as to uncover novel ones. Mycobacterial
FASII undertakes mycolic acid biosynthesis, which relies
on a set of essential enzymes, including 3-oxoacyl-AcpM
reductase FabG1/Rv1483. However, the M. tuberculosis
genome encodes four additional FabG homologs, desig-
nated FabG2–FabG5, whose functions have hitherto not
been characterized in detail. Of the four candidates, FabG4/
Rv0242c was recently shown to be essential for the survival
of M. bovis BCG. The present work was initiated by assess-
ing the suitability of yeast oar1 mutant cells lacking mito-
chondrial 3-oxoacyl-ACP reductase activity to act as a
surrogate system for expressing FabG1/MabA directed to
the mitochondria. Mutant yeast cells producing this tar-
geted FabG1 variant were essentially wild type for all of the
chronicled phenotype characteristics, including respiratory
growth on glycerol medium, cytochrome assembly and
lipoid acid production. This indicated that within the frame-
work of de novo fatty acid biosynthesis in yeast mitochon-
dria, FabG1 was able to act on shorter (C4) acyl substrates
than was previously proposed (C8–20) during mycolic acid
biosynthesis in M. tuberculosis. Thereafter, FabG2–FabG5
were expressed as mitochondrial proteins in the oar1
strain, and FabG4 was found to complement the mutant
phenotype and contain high levels of 3-oxoacyl-thioester
reductase activity. Hence, like FabG1, FabG4 is also an
essential, physiologically functional 3-oxoacyl-thioester
reductase, albeit the latter’s involvement in mycobacterial
FASII remains to be explored.
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Abbreviations
ACP Acyl carrier protein
AcpM Mycobacterial ACP
BCG Bacillus Calmette-Guérin
FAS Fatty acid synthase
FASI Type 1 associative FAS
FASII Type 2 dissociative FAS
MLS Mitochondrial leader sequence
ORF Open reading frame
PCR Polymerase chain reaction
MFE2 Peroxisomal type 2 multifunctional enzyme
Introduction
Mycobacterium tuberculosis is the main cause of death due
to a single infectious agent (World Health Organisation
1997) among humans, and as many as 2 billion people
worldwide are infected with tuberculosis (for a review, see
Takayama et al. 2005 and references cited therein). In light
of the rise in mycobacterial resistance toward isoniazid,
which represents one of less than a handful of Wrst-line anti-
tuberculous drugs, there is an urgent need to widen the
study of vital M. tuberculosis processes so as to develop
novel drugs.
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(Banerjee et al. 1994), which are very long-chain -branched
-hydroxylated fatty acids (C54–63) that help form the pro-
tective layer around this pathogen, thereby adding to its
persistence and virulence (Takayama et al. 2005). Mycolic
acid biosynthesis involves a combination of an associative
type 1 fatty acid synthase (FASI) similar to the system
found in the eukaryotic cytosol, in that it comprises several
enzymatic activities located on a single multifunctional
synthase (Bloch 1977) and a dissociative type 2 process
(FASII) resembling the plant–plastid system that consists
of separate enzymes. FASII also occurs in yeast mitochon-
dria (reviewed in Hiltunen et al. 2005).
In M. tuberculosis FASII, FabG1 (MabA) undertakes the
reduction of 3-oxoacyl-acyl carrier protein (AcpM) to gen-
erate 3-hydroxyacyl-AcpM (Banerjee et al. 1998), whereas
in the equivalent mitochondrial process in Saccharomyces
cerevisiae, this step is catalyzed by Oar1p (Schneider et al.
1997). In reference to substrate speciWcities, FabG1 has
been demonstrated previously to catalyze the NADP(H)-
speciWc reduction of long-chain (C8–20) 3-oxoacyl-thioester
species. Molecular modeling of FabG1 revealed a large
substrate-binding pocket capable of accommodating long-
chain substrates (Marrakchi et al. 2002), while yeast Oar1p
is presumed to act on only short-chain ones. Analysis of the
complete sequence of the M. tuberculosis genome (Cole
et al. 1998) revealed FabG1 as having four homologs,
termed FabG2–FabG5 (Fig. 1), but, so far, not one of them
has been fully characterized.
The essential requirement for FabG activity has been
addressed before in a genome-wide survey using transpo-
son-site hybridization, which revealed just over 600
M. tuberculosis genes that were required for optimal
growth (Sassetti et al. 2003), among them fabG2/Rv1350.
However, a subsequent study identifying almost 200 M.
tuberculosis genes that were required for mycobacterial
survival during infection did not pick up a single fabG
locus (Sassetti and Rubin 2003). The dispute surrounding
the requirement for 3-oxoacyl-thioester activity in myco-
bacteria was Wnally settled with the Wnding that FabG1 is in
fact essential for M. tuberculosis survival (Parish et al.
2007), whereas in M. bovis BCG, FabG1 and the hitherto
uncharacterized FabG4 have both been exposed as being
vital (Beste et al. 2009).
Fig. 1 Homology study of M. tuberculosis FabG proteins. Multalin-
and Genedoc-based comparison of the deduced amino acid sequence
of FabG1 (Rv1483) with those of its homologs FabG2 (Rv1350),
FabG3 (Rv2002), FabG4 (Rv0242c) and FabG5 (Rv2766c). Dashes
indicate the arrangement of the sequences for best Wt, and arrows point
to the amino acids forming the catalytic triad (Marrakchi et al. 2002).
The Wrst 150 amino acid residues of FabG4 do not match any of those
of the other homologs, and were removed from the Wgure. Black shad-
ings refer to strictly conserved amino acid residues among all the
sequences, whereas the darker and lighter gray shadings denote
regions with more relaxed residue similarities not necessarily shared
by the full set of sequences123
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bovis BCG raised the pertinent question of whether a simi-
lar situation might also occur in M. tuberculosis, whereby
FabG1 is not necessarily the sole essential 3-oxoacyl-thio-
ester reductase after all. This prompted the deployment of
an alternative strategy for studying the functions of the
remaining four FabG homologs. To this end, S. cerevisiae
was exploited as a surrogate host for investigating M.
tuberculosis proteins (Gerum et al. 2002) with potential
FASII activities. Here, mitochondrially targeted versions of
FabG1 to FabG5 were expressed in yeast oar1 mutant
cells (Schneider et al. 1997), which lack 3-oxoacyl-ACP
reductase activity and do not respire or grow on glycerol,
assemble cytochrome complexes or produce lipoic acid.
The eVects were compared to those of ectopically express-
ing native Oar1p. This oar1 strain was applied previously
to expose the identity of nematode and human 3-oxoacyl-
thioesters (Gurvitz 2009; Chen et al. 2009). The outcome of
this study is discussed in terms of the identiWcation of the
essential mycobacterial fabG4 gene as encoding a novel
3-oxoacyl-thioester reductase, as well as the role of pro-
tein–protein interactions in mycobacterial FASII.
Materials and methods
S. cerevisiae strains, plasmids and oligonucleotides
Yeast strains, plasmids and oligonucleotides used are listed
in Table 1. The Escherichia coli strain TOP10 F was used
for all plasmid ampliWcations and isolations. The wild-type
yeast strain BY4741 and its oar1 derivative were obtained
from EUROSCARF (www.uni-frankfurt.de). To generate
strains yPLM37 to yPLM43, plasmids were introduced into
BY4741oar1 cells using a published protocol (Chen et al.
1992), and transformants were selected on solid synthetic
deWned glucose (SD-Ura) medium lacking uracil.
Plasmid constructions
DNA manipulations and plasmid constructions were per-
formed according to standard techniques (Ausubel et al.
1989). The Wve fabG genes were isolated from H37Rv
genomic DNA by polymerase chain reaction (PCR) using
Phusion high-Wdelity DNA polymerase (Finnzymes Oy,
Espoo, Finland) and the corresponding oligonucleotides
(Table 1), as described previously (Gurvitz et al. 2008a,b,
2009). Electrophoretic resolution of the PCR products, and
their excision, puriWcation and subsequent ligation to an
EcoRV-digested pBluescript plasmid vector (Stratagene,
La Jolla, CA) were performed as done previously (Gurvitz
et al. 2008b). The Wve pBluescript inserts were subcloned
following digestion with NcoI and HindIII restriction
enzymes, and ligated behind the CTA1 promoter within a
similarly digested plasmid pYE352:mitQOR (pPLM62). As
a result of this digestion, the QOR open reading frame
(ORF) encoding E. coli quinone reductase was removed to
leave behind the nucleotides for the yeast Coq3p (Hsu et al.
1996) mitochondrial leader sequence (MLS), as described
in the literature (Torkko et al. 2001; Gurvitz et al. 2008b).
Following import into the mitochondria, the fused MLS is
cleaved oV to leave behind a shorter fusion protein pre-
ceded by eight amino acids remaining from the MLS fusion
(Torkko et al. 2001). Nucleotide sequencing of the fabG
inserts veriWed that no mutations were introduced during
the ampliWcation process and that the COQ3-fabG junction
remained intact. Construction of plasmid YEp352:OAR1
(pPLM188) expressing S. cerevisiae mitochondrial OAR1
from the CTA1 promoter is described (Chen et al. 2009).
BrieXy, the OAR1 ORF was ampliWed from yeast genomic
DNA using standard procedure and, following digestion
with the appropriate restriction enzymes, the PCR product
was ligated to a similarly digested pYE352:CTA1 (Filppula
et al. 1995), from which the CTA1 ORF was removed
(Chen et al. 2009).
Media and growth conditions
Standard yeast (Rose et al. 1990) and E. coli (Sambrook
et al. 1989) media were prepared as described. S. cerevisiae
strains were propagated on solid, rich glucose medium
YPD consisting of 1% (wt/vol) yeast extract, 2% (wt/vol)
peptone (YP), 2% (wt/vol) D-glucose and 2% (wt/vol) agar.
YEp352-based episomal plasmids marked with the URA3
gene (Hill et al. 1986) were maintained in transformed
strains on solid, synthetic deWned (SD-Ura) medium con-
sisting of 0.67% (wt/vol) yeast nitrogen base without amino
acids, 2% (wt/vol) D-glucose and 3% (wt/vol) agar, with all
necessary supplements added except for uracil (Sigma–
Aldrich Inc., MO, USA). Synthetic complete glycerol
(SCglycerol) medium was prepared essentially as SD-Ura,
except that uracil was added and glucose was replaced with
3% (wt/vol) glycerol. Induction of yeast cells in oleic acid
medium has been described previously (Gurvitz et al.
1997).
Miscellaneous
For 3-oxoacyl-thioester reductase activity assays, soluble
protein extracts were prepared from yeast cells that were
propagated in oleic acid medium and processed as
described (Gurvitz et al. 2008a,b, 2009). Protein concentra-
tions were determined according to a published method
(Bradford 1976). Reductase activity was assayed spectro-
photometrically at 23°C as described (Dommes and Kunau
1984). The reductase activity assay mixture consisted of123
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2.0 l puriWed protein representing the hydratase 2 domain
from Drosophila melanogaster MFE2 (unpublished),
125 M NADP+ or NAD+, and 60 M 2-trans-decenoyl-
CoA or 2-trans-hexenoyl-CoA that were synthesized via
the mixed anhydride system (Goldman and Vagelos 1961).
Reduction of the electron carrier was monitored spectro-
photometrically at 340–385 nm. The assembly of cytochrome
complexes was followed with a spectrophotometer at
480–640 nm, using yeast cells that were applied as a thick
paste onto the glass surface of an otherwise aluminum
cold-temperature cuvette, which was chilled in liquid
nitrogen (Lindenmayer and Estabrook 1958). The lipoic
acid content of yeast strains was monitored by a biological
assay as described previously (Brody et al. 1997; Hayden
et al. 1993). Operon prediction was undertaken using
Table 1 S. cerevisiae strains, plasmids and oligonucleotides used
a The numbers in superscript following the designation of the strains refer to their parental genotypes, e.g., BY4741oar11 was derived from (1)
BY4741. The same principle applies to plasmids
Strain, plasmid, oligonucleotide Description Source or reference
S. cerevisiae
(1) BY4741 MATa his31 leu20 met150 ura30 EUROSCARF
(2) BY4741oar11a ykl055c::kanMX EUROSCARF
yPLM372 Expressing peroxisomal catalase A (Cta1p) from pPLM187 This study
yPLM382 Expressing mitochondrial Coq3p-FabG1 from pPLM189 This study
yPLM392 Expressing mitochondrial Coq3p-FabG2 from pPLM190 This study
yPLM402 Expressing mitochondrial Coq3p-FabG3 from pPLM191 This study
yPLM412 Expressing mitochondrial Coq3p-FabG4 from pPLM192 This study
yPLM422 Expressing mitochondrial Coq3p-FabG5 from pPLM193 This study
yPLM432 Expressing mitochondrial Oar1p from pPLM188 This study
Plasmid
(3) pBluescript KS III pKS cloning vector Stratagene
pPLM833 pKS:Rv1483 mitochondrial fabG1 in pBluescript This study
pPLM823 pKS:Rv1350 mitochondrial fabG2 in pBluescript This study
pPLM863 pKS:Rv2002 mitochondrial fabG3 in pBluescript This study
pPLM783 pKS:Rv0242c mitochondrial fabG4 in pBluescript This study
pPLM963 pKS:Rv2766c mitochondrial fabG5 in pBluescript This study
(4) YEp352 URA3-marked multicopy plasmid Hill et al. (1986)
(5) pPLM1874 CTA1 behind its promoter (pYE352:CTA1) Filppula et al. (1995)
pPLM1885 OAR1 behind the CTA1 promoter (pYE352:OAR1) Chen et al. (2009)
(6) pPLM625 COQ3-QOR fusion behind the CTA1 promoter Torkko et al. (2001)
pPLM1896 COQ3-fabG1 fusion behind the CTA1 promoter This study
pPLM1906 COQ3-fabG2 fusion behind the CTA1 promoter This study
pPLM1916 COQ3-fabG3 fusion behind the CTA1 promoter This study
pPLM1926 COQ3-fabG4 fusion behind the CTA1 promoter This study
pPLM1936 COQ3-fabG5 fusion behind the CTA1 promoter This study
Oligonucleotide
Rv1483 MLS-FabG1 F 5-TTATCCATGGCTGCCACAGCCACTGAAGGGGC-3 This study
Rv1483 FabG1 R 5-TATTAAGCTTCAGTGGCCCATACCCATGCC-3 This study
Rv1350 MLS-FabG2 F 5-TTATCCATGGCGTCATTGCTGAACGCTC-3 This study
Rv1350 FabG2 R 5-TATACTCGAGTCATATGAACCGGCCGCCAG-3 This study
Rv2002 MLS-FabG3 F 5-TTATCCATGGCTGGACGGTTGATAGGAAAGG-3 This study
Rv2002 FabG3 R 5-TATTAAGCTTACGTCACCCATTCCGGCTGCG-3 This study
Rv0242c MLS-FabG4 F 5-TTATCCATGGCTCCCAAGCGTTCGTCCGATC-3 This study
Rv0242c FabG4 R 5-TATTAAGCTTCACGCGCCGATCATGGCCTGGC-3 This study
Rv2766c MLS-FabG5 F 5-TTATTATCATGACCTCACTGGATCTGACC-3 This study
Rv2766c FabG5 R 5-TTATTATCATGACCTCACTGGATCTGACC-3 This study123
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operons.cgi). Multalin (npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.
pl?page =/NPSA/npsa_multalin.html) and Genedoc (www.
nrbsc.org/gfx/genedoc/index.html) were used to generate
the sequence comparison in Fig. 1.
Results
Mycobacterial FabG1 and FabG4 restore respiratory 
growth of S. cerevisiae oar1 cells
The M. tuberculosis genome (Cole et al. 1998) contains Wve
genes with the potential to encode 3-oxoacyl-AcpM reduc-
tases, termed fabG1 to fabG5 (Takayama et al. 2005).
FabG1 is chronicled as a 3-oxoacyl-AcpM reductase
involved in mycolic acid biosynthesis (Banerjee et al. 1998;
Marrakchi et al. 2002); however, the function of the
remaining four homologs has hitherto remained unknown.
To determine whether these could encode 3-oxoacyl-thio-
ester reductases, FabG1–FabG5 were expressed as fusion
constructs that were preceded by the Coq3p mitochondrial
leader sequence (Hsu et al. 1996) so as to generate mitoc-
hondrially targeted versions. The Wve fusions were tethered
behind the promoter of the CTA1 gene encoding peroxi-
somal catalase A (Cta1p), which is only moderately
de-repressed on non-fermentable carbon sources such the
glycerol is used here for complementation assays (Filipits
et al. 1993; Rottensteiner et al. 1996). These tests were per-
formed on yeast cells lacking Oar1p that have been
exploited previously to demonstrate the physiological func-
tion of ectopically expressed 3-oxoacyl-ACP reductases
(Gurvitz 2009; Chen et al. 2009).
Mutant oar1 yeast cells were transformed with multi-
copy episomal plasmids loaded with the fusion constructs.
Following selection on synthetic deWned glucose medium
lacking uracil (SD-Ura), survivors were streaked on syn-
thetic complete medium containing glycerol (SCglycerol)
as the sole carbon source. Only those mutants expressing
FabG1 or FabG4 were capable of forming single colonies
on this medium type. A dedicated analysis of the reasons
for the failure of FabG2, FabG3 or FabG5 to achieve phe-
notype rescue was beyond the scope of the present study,
these causes being all the more enigmatic since no obvious
diVerences among the homologs emerged from the data
shown in Fig. 1.
To demonstrate more accurately that expression of mito-
chondrial versions of FabG1 or FabG4 in the oar1 mutant
cells could compensate for the missing activity attributed to
native Oar1p, the four strains (each expressing FabG1,
FabG4, Oar1p or Cta1p) were propagated overnight in
liquid SD-Ura medium. Following tenfold serial dilution,
cultures were spotted onto solid SD-Ura (glucose) or
SCglycerol (glycerol) media, and the plates were incubated
at 30°C until single colonies were detectable (Fig. 2). As
anticipated, mutant oar1 cells expressing Oar1p could
form single colonies on glycerol, whereas those cells
expressing Cta1p were not able to proliferate on this
medium, vindicating the experimental design. Importantly,
the results demonstrated that the respiratory deWcient phe-
notype of the oar1 mutant could be rescued by FabG1 and
FabG4, indicating functional complementation.
Fig. 2 Growth of S. cerevisiae oar1 mutants expressing M. tubercu-
losis FabG1 or FabG4. Yeast oar1 cells expressing native mitochon-
drial 3-oxoacyl-ACP reductase (Oar1p positive control), native
peroxisomal catalase A (Cta1p negative control), mitochondrially tar-
geted FabG1 or mitochondrially targeted FabG4 were grown in liquid
SD-Ura medium that selected for plasmid presence. Following serial
dilution, cells were applied to solid (SD-Ura) glucose or (SCglycerol)
glycerol media. The plates were incubated at 30°C until single colonies
appeared and recorded photographically. The yPLM strains used were
37, 38, 41 and 43123
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3-oxoacyl-thioester reductase activity
Soluble protein extracts from BY4741oar1 cells expressing
M. tuberculosis FabG1 or FabG4 were examined for
3-oxoacyl-thioester reductase activity using 2-trans-
hexenoyl-CoA (trans-C6:1(2)) or 2-trans-decenoyl-CoA
(trans-C10:1(2)) as substrates. The reactions additionally
included puriWed protein consisting of the hydratase 2
domain from Drosophila melanogaster peroxisomal type 2
multifunctional enzyme (MFE2), which hydrated the sub-
strates to generate the 3-hydroxyacyl-CoA species that
could be metabolized, in the reverse reaction, by the 3-oxo-
acyl-thioester reductases examined. The reactions were
monitored spectrophotometrically at wavelengths of 340–
385 nm, by following the reduction of NADP+ or NAD+ to
their corresponding protonated species (Gurvitz 2009).
Both electron carrier types were considered in this assay, as
recent work revealed that 3-oxoacyl-thioester reductase
activity might actually depend on NAD(H), poignantly evi-
denced by the nematode and human 3-oxoacyl-ACP
reductases of mitochondrial FASII (Gurvitz 2009; Chen
et al. 2009).
To obtain high levels of protein expression from the fatty
acid-inducible CTA1 promoter (Filipits et al. 1993; Rotten-
steiner et al. 1996), cells were grown overnight on oleic
acid medium. The results of the enzyme assays with
2-trans-hexenoyl-CoA as substrate and NADP+ as cofactor
(in the presence of hydratase 2 activity) performed on
oar1 cells over-expressing native Oar1p or Cta1p indi-
cated that any reductase activity present was below the
detection limit of the assay used. Recent work on Oar1p by
others revealed that its 3-oxoacyl-thioester reductase
activity could only be detected in assays performed on a
recombinant protein (Chen et al. 2009). Similarly, it was
impossible to detect any activity in soluble protein extracts
obtained from oar1 cells over-expressing FabG1 when
NADP(H) was supplied as cofactor in the reaction, but this
was anticipated since previous measurements were also
performed solely on a recombinant protein (Marrakchi
et al. 2002). Surprisingly, a volume of 0.1 l of soluble pro-
tein extract containing approximately 5 mg/ml protein from
mutant cells over-expressing FabG4 gave rise to an
NAD(H)-dependent oxidation of the C6 substrate at the rate
of 0.21 § 0.02 (SD, n = 3) mol/mg protein £ min¡1
(Table 2). When the C10 substrate was used under the same
reaction conditions, the soluble extracts containing FabG4
yielded a rate of 0.25 § 0.08 (SD, n = 3) mol/mg protein £
min¡1 (Table 2). Further examination of FabG4 extracts
with NADP+ and C6 resulted in a rate of 3.5 § 0.3 (SD,
n = 3) nmol/mg protein £ min¡1 (Table 2), indicating that
FabG4 might also utilize NADP(H), albeit ineYciently.
Hence, heterologous expression of FabG4 in mutant oar1
cells resulted in protein extracts containing readily detect-
able levels of 3-oxoacyl-thioester reductase activity.
FabG1 and FabG4 restore the assembly of cytochrome 
complexes in the oar1 mutant
Yeast cells carrying a deletion at the OAR1 gene have pre-
viously been shown to lack assembled cytochrome com-
plexes (Schneider et al. 1997). Hence, rescue of oar1 cells
from their fermentative phenotype should be associated
with re-assembly of these structures. To verify this recov-
ered function by means of a qualitative assay, the yeast
strains described in “Yeast oar1 cells expressing FabG4
contain 3-oxoacyl-thioester reductase activity” were moni-
tored for cytochrome complex assembly using the cold-
temperature cuvette method (Lindenmayer and Estabrook
1958). Cell pastes were collected and applied to cuvettes
that were then immersed in liquid nitrogen prior to being
placed in a spectrophotometer. The result demonstrated
that oar1 cells expressing peroxisomal Cta1p were not
eYcient at assembling the complete retinue of the cyto-
chrome complexes (e.g., complexes a and a3; Fig. 3). On
the other hand, the signals representing these complexes
were more pronounced in mutant cells expressing native
Oar1p or mycobacterial FabG1 and FabG4. Hence, this
indicated that the ability of oar1 mutants to grow on glyc-
erol was coincidental with the recuperation of cytochrome
complex assembly in their mitochondria.
Expression of FabG1 or FabG4 renews lipoic acid 
production in the oar1 mutant
Previous work demonstrated that the C8 octanoic acid prod-
uct of mitochondrial FASII acts as the starting point for the
synthesis of lipoic acid, and that a mutation in any one of
the yeast genes encoding mitochondrial FASII enzyme
causes a dramatic drop in the levels of lipoic acid (Hiltunen
et al. 2005). However, this deWciency can be reversed when
such mutants are supplied with known or presumed FASII
enzyme activities of the corresponding type. To link FabG1
Table 2 Enzyme activities in a yeast oar1 mutant expressing FabG4
a The values are means § standard deviations (n = 3) and represent
averages of measurements using extracts obtained from three indepen-
dent yeast cultures following overnight oleic acid induction. The yeast
strain used was yPLM41
Substrate 3-Oxoacyl-thioester reductase 
activity (nmol/mg protein £ min¡1)
NAD(H) NADP(H)
2-trans-hexenoyl-CoA 210 § 20a 3.5 § 0.3
2-trans-decenoyl-CoA 250 § 80 Not tested123
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yeast mitochondria, lipoic acid levels were examined in the
four strains using an in vivo growth assay that exploits a
lipoic acid-deWcient E. coli strain (Brody et al. 1997;
Hayden et al. 1993). Extracts prepared from the negative
control strain expressing Cta1p supported only a nominal
growth level of these E. coli cells, commensurate with 7 ng
lipoic acid present per gram wet weight of yeast cells
(Table 3). In contrast, yeast mutant cells expressing native
Oar1p produced suYcient amounts of lipoic acid to support
levels of bacterial growth equivalent to 193 ng of lipoic
acid per gram wet weight. Importantly, expression of
FabG1 or FabG4 in the yeast mutant resulted in extracts
containing the respective lipoic acid levels of 174 and
164 ng of lipoic acid per gram wet weight, which were over
20-fold higher than the levels of the negative control,
thereby underscoring further the function of FabG4 as a
putative FASII-like 3-oxoacyl-thioester reductase.
Discussion
The identiWcation of a novel 3-oxoacyl-thioester reductase
encoded by the essential mycobacterial gene fabG4 is
described herein. The report takes into account the Wndings
whereby FabG4 (1) restored the respiratory growth of an
otherwise obligatory fermentative yeast mutant devoid of
Oar1p; (2) contained high levels of 3-oxoacyl-thioester
reductase activity; and (3) replaced Oar1p during lipoic
acid synthesis. Future experimentation dedicated to knock-
ing out fabG4 would likely help to elucidate whether
FabG4 is in fact vital for M. tuberculosis persistence and
virulence. Nevertheless, since FabG4 was practically indis-
tinguishable from the essential mycobacterial 3-oxoacyl-
AcpM reductase FabG1 within the parameters of phenotype
rescue in yeast, it is attractive to speculate that FabG4
might also be involved in some hitherto elusive aspect of
fatty acid biosynthesis in M. tuberculosis. Additional
important results to emerge here regarding FabG1 include
the reWnement of its in vivo substrate speciWcities (down to
C4), as well as exposure of its ability to function in yeast
without resorting to protein–protein interactions with other
mycobacterial FASII enzymes.
The role of FabG1 has been described previously within
the context of mycobacterial FASII, which is outlined in
great detail in Takayama et al. (2005). FASII begins with a
C20-CoA intermediate emerging from FASI, with addi-
tional rounds of C2 extensions being undertaken by FASII
so as to arrive at the Wnal length (up to C63) required for
incorporation into mature mycolic acids. In a FASII pre-
step, 3-oxoacyl-AcpM synthase mtFabH (see below) con-
verts the incoming C20-CoA to a (C22) 3-oxoacyl-AcpM
based on the availability of C3 malonyl-AcpM. Further
FASII extensions are eVected by two additional 3-oxoacyl-
AcpM synthases, represented by KasA and KasB, giving
rise to a 3-oxoacyl-AcpM intermediate. This metabolite
acts as substrate for the aforementioned FabG1, which
reduces the latter intermediary to 3-hydroxyacyl-AcpM,
with the concomitant oxidation of NADPH. The subsequent
Fig. 3 Spectrophotometric assay for mitochondrial cytochrome
complexes. Cell pastes from the indicated strains were collected from
liquid cultures that were cultivated overnight in oleic acid medium and
applied to the glass face of otherwise aluminum cold-temperature
cuvettes that were immersed in liquid nitrogen prior to being placed in
a spectrophotometer for analysis. The pastes were scanned at wave-
lengths between 480 and 640 nm. Numbers to the left indicate units of
absorbance (ABS), those at the bottom refer to wavelength in nm.
Peaks corresponding to known cytochromes are indicated (letters with
arrows). The yPLM strains used were 37, 38, 41 and 43
Table 3 Lipoic acid production in yeast oar1 mutants expressing
the listed proteins
a The values are means § standard deviations (n = 3) and represent
averages of three independent bacterial growth responses. The S. cere-
visiae yPLM strains used were 37, 38, 41 and 43
Protein Lipoic acid content 
(ng/g [wet weight])
Cta1p 7 § 2
Oar1p 193 § 7a
FabG1 174 § 22
FabG4 164 § 23123
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With reference to the non-rescuing FabG homologs, the
published data for FabG2, FabG3 and FabG5 remain rather
scant. The crystal structure of FabG3/Rv2002 has been
determined, but there are no data available on its physiolog-
ical function or enzyme activity (Yang et al. 2002). Another
homolog, FabG5/Rv2766c, was picked up with additional
proteins (including InhA and the isoniazid-sensitive dihy-
drofolate reductase DfrA) in a screen for proteins capable
of interacting with a resin mimicking the isoniazid–NAD/P
adduct formed with the active species of isoniazid (Argyrou
et al. 2006). Interestingly, isoniazid-sensitive FabG1 itself
(Banerjee et al. 1998; Ducasse-Cabanot et al. 2004) was not
identiWed in this search. In the aforementioned scan for
genes needed for optimal growth (Sassetti et al. 2003), of
the Wve fabG genes only fabG2/Rv1350 was found to be
required for this parameter. Moreover, none of them came
up in a transposon-based screen for altered virulence
(McAdam et al. 2002), or was upregulated in M. tuberculo-
sis treated with isoniazid and other antimicrobials (Betts
et al. 2003). Hence, further work will be required to under-
pin the functions of the remaining FabG homologs. This
notwithstanding, it should be noted that since the present
study was conducted entirely in a yeast background, the
observations presented here may not necessarily apply to
mycobacterial biochemistry. In other words, because phe-
notype rescue could not be achieved with the remaining
three homologs, it would be premature to proclaim that
they do not in fact play a role in fatty acid biosynthesis.
Returning to the essential requirement of FabG4 for
mycobacterial existence, although an M. tuberculosis
mutant knockout at fabG4 has been reported previously to
be symptomless in the context of survival during infection
(Sassetti and Rubin 2003), very important recent studies
revealed fabG4 (as well as fabG1, fabD and acpS, all aYli-
ated with FASII) to be essential, at least in terms of growth
of M. bovis BCG on Roisin’s medium (Beste et al. 2009).
Interestingly, the fabG4 locus (Rv0242c) occurs in close
proximity to that of htdX (Rv0241c), whose latter product
has been shown recently to act in yeast hdt2 cells as a
physiological 3-hydroxyacyl-thioester dehydratase (Gurvitz
et al. 2009). This represents the enzyme activity following
FabG in the fatty acid biosynthesis scheme, and the two
genes are predicted to occur in a single operon (operonDB;
conWdence = 84; n = 57). Since similar pair arrangements
have been observed in M. tuberculosis with other genes of
mycolic acid biosynthesis, including Rv1484/inhA and
Rv1483/fabG1 (Takayama et al. 2005), it is at least plausi-
ble that HtdX and FabG4 might also function within a
shared FASII-like pathway.
Regarding the issue of whether FabG1 is essential for
pathogen survival, this has only recently been resolved.
A study dedicated to addressing this speciWc issue revealed
that knocking out the gene for FabG1 in the pathogen was
only possible if an additional plasmid-borne gene copy was
made available, a procedure formally accepted as genetic
proof for the essentiality of this gene (Parish et al. 2007).
Although the requirement for FabG1 in M. tuberculosis
could be compensated by using the homologous protein
from M. smegmatis, functional complementation of the
mycobacterial mutant devoid of its native FabG1 could not
be achieved using an ectopically expressed E. coli FabG. It
was argued that failure to complement the mutant pheno-
type using the bacterial protein was likely due to structural
diVerences between the bacterial and mycobacterial pro-
teins (Parish et al. 2007), in that the former is not able to
accommodate long-chain fatty acids or undertake the sug-
gested speciWc protein–protein interactions necessary for
FASII (Veyron-Churlet et al. 2004, 2005).
Hence, the Wnding here that FabG1 could alleviate the
growth phenotype of oar1 mutant cells was remarkable in
light of the conclusions drawn regarding the central posi-
tion of FabG1 in the complex presumed to exist within the
structure of mycobacterial FASII (Veyron-Churlet et al.
2004). Using the yeast two-hybrid approach, native FabG1
was shown to interact only very weakly with the aforemen-
tioned FabH, albeit subsequent co-immunoprecipitation
failed to conWrm this putative interaction altogether. Never-
theless, mutant versions of FabG1 were constructed so that
they failed to form the native FabG1 multimer; these dis-
played more extensive protein–protein interactions, namely
with the previously mentioned KasA, KasB, and FabH.
Based on the results with these mutant FabG1 monomers,
the authors concluded that the wild-type FabG1 monomer
must also interact with each of the aforementioned con-
densing enzymes in the native state, and that the high pro-
pensity of these monomers to multimerize helps maintain
the macromolecular organization of FASII. Since expres-
sion of these FabG1 mutants in M. tuberculosis appeared to
block FASII, presumably by forming unproductive FabG1
multimers, this led to the suggestion that the quaternary
structure of FabG1 is critical for a functional FASII com-
plex (Veyron-Churlet et al. 2004). The conclusion that
FabG1 represents a pivotal interacting protein that is vital
for maintaining FASII complexes in M. tuberculosis is
diYcult to reconcile with the observations made here,
whereby FabG1 could function in yeast FASII to 90%
eYciency (Table 3) in an environment within which it has
clearly not evolved to form highly speciWc protein–protein
interactions.
A further point of contention regarding FabG1 is its
physiological substrate speciWcity. Previous work on
recombinant FabG1 showed that it was active in vitro using
C4 acetoacetyl-CoA as substrate (Banerjee et al. 1998;
Ducasse-Cabanot et al. 2004). However, other studies123
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CoA substrates, and that it metabolizes the C4 substrate
only poorly (Marrakchi et al. 2002). Unfortunately, even
following extensive over-expression in cells grown on oleic
acid medium, the enzyme assay used here failed to detect
any reductase activity for FabG1 using C6 or C10 substrates.
Nevertheless, it can still be concluded that, at least within
an in vivo yeast context, FabG1 was almost as eYcient as
native Oar1p in metabolizing short-chain C4–8 substrates,
despite fabG1 being expressed at only modest levels com-
mensurate with glucose derepression. Herein lays one of
the major advantages of using yeast for examining the in
vivo eYcacy of enzymes for substrates that are otherwise
not metabolized facilely in vitro. It is predicted that yeast
FASII mutants will continue to serve as a convenient tool
for identifying novel pathogen proteins.
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